Altered biliary epithelial cell and monocyte responses to lipopolysaccharide as a TLR ligand in patients with primary biliary cirrhosis

References

• Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261–73.
   PubMed Web of Science ®Google Scholar
• Haydon GH, Neuberger J. PBC: an infectious disease? Gut 2000;47:586–8.
   PubMed Web of Science ®Google Scholar
• Okada C, Akbar SM, Horiike N, Onji M. Early development of primary biliary cirrhosis in female C57BL/6 mice because of poly I:C administration. Liver Int 2005;25:595–603.
   PubMed Web of Science ®Google Scholar
• Kikuchi K, Lian ZX, Kimura Y, Selmi C, Yang GX, Gordon SC, Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis. J Autoimmun 2005;24:347–52.
   PubMed Web of Science ®Google Scholar
• Hiramatsu K, Harada K, Tsuneyama K, Osnes M. Amplification and sequence analysis of partial bacterial 16S ribosomal RNA gene in gallbladder bile from patients with primary biliary cirrhosis. J Hepatol 2000;33:9–18.
   PubMed Web of Science ®Google Scholar
• Yeaman SJ, Kirby JA, Jones DE. Autoreactive responses to pyruvate dehydrogenase complex in the pathogenesis of primary biliary cirrhosis. Immunol Rev 2000;174:238–49.
   PubMed Web of Science ®Google Scholar
• Feld JJ, Meddings J, Heathcote EJ. Abnormal intestinal permeability in primary biliary cirrhosis. Dig Dis Sci 2006;51:1607–13.
   PubMed Web of Science ®Google Scholar
• Freudenberg MA, Galanos C. Bacterial lipopolysaccharides: structure, metabolism and mechanisms of action. Int Rev Immunol 1990;6:207–21.
   PubMedGoogle Scholar
• Freudenberg MA, Merlin T, Gumenscheimer M, Kalis C, Landmann R, Galanos C. Role of lipopolysaccharide susceptibility in the innate immune response to Salmonella typhimurium infection: LPS, a primary target for recognition of Gram-negative bacteria. Microbes Infect 2001;3:1213–22.
   PubMedGoogle Scholar
• Freudenberg MA, Tchaptcheta S, Kecka S, Fejera G, Huberb M, Schützec N, Lipopolysaccharide sensing an important factor in the innate immune response to Gram-negative bacterial infections: benefits and hazards of LPS hypersensitivity. Immunobiology 2008;213:193–203.
   PubMed Web of Science ®Google Scholar
• Selmi C, Mackay IR, Gershwin ME. The immunological milieu of the liver. Semin Liver Dis 2007;27:129–39.
   PubMed Web of Science ®Google Scholar
• Osnes T, Sandstad O, Skar V, Osnes M. Lipopolysaccharides and betaglucuronidase activity in choledochal bile in relation to choledocholithiasis. Digestion 1997;58:437–43.
   PubMed Web of Science ®Google Scholar
• Sasatomi K, Noguchi K, Sakisaka S, Sata M, Tanikawa K. Abnormal accumulation of endotoxin in biliary epithelial cells in primary biliary cirrhosis and primary sclerosing cholangitis. J Hepatol 1998;29:409–16.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Sezai S, Sakurabayashi S, Hirano M, Kamisaka K, Oka H. A study of endotoxaemia in patients with primary biliary cirrhosis. J Int Med Res 1994;22:95–9.
   PubMedGoogle Scholar
• Ballot E, Bandin O, Chazouilleres O, Johanet C, Poupon R. Immune response to lipopolysaccharide in primary biliary cirrhosis and autoimmune diseases. J Autoimmun 2004;22:153–8.
   PubMed Web of Science ®Google Scholar
• Harada K, Nakanuma Y. Biliary innate immunity and cholangiopathy. Hepatol Res 2007;37:S430–7.
   Web of Science ®Google Scholar
• Goldstein DR. Links between innate and acquired immunity. Curr Opin Immunol 2004;16:538–44.
   PubMedGoogle Scholar
• Uematsu S, Akira S. Toll-Like receptors (TLRs) and their ligands. Handb Exp Pharmacol 2008;183:1–20.
   PubMedGoogle Scholar
• Cook DN, Pisetsky DS, Schwartz DA. Toll-like receptors in the pathogenesis of human disease. Nat Immunol 2004;5:975–9.
   PubMed Web of Science ®Google Scholar
• Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449:819–26.
   PubMed Web of Science ®Google Scholar
• Jiang Q, Akashi S, Miyake K, Petty HR. Lipopolysaccharide induces physical proximity between CD14 and toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-kappa B. J Immunol 2000;165:3541–4.
   PubMed Web of Science ®Google Scholar
• Chow JC, Young DW, Golenbock DT, Christ WJ, Gusovsky F. Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction. J Biol Chem 1999;274:10689–92.
   PubMed Web of Science ®Google Scholar
• Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006;124:783–801.
   PubMed Web of Science ®Google Scholar
• Hirschfield GM, Siminovitch KA. Toward the molecular dissection of primary biliary cirrhosis. Hepatology 2009;50:1347–50.
   PubMedGoogle Scholar
• Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, Cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J Immunol 2000;164:3471–5.
   PubMed Web of Science ®Google Scholar
• Miller SI, Ernst RK, Bader MW. LPS, TLR4 and infection disease diversity. Nature 2005;3:36–46.
   Google Scholar
• Heathcoat EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines. Hepatology 2000;31:1005–13.
   PubMedGoogle Scholar
• Chazouillères O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: clinical features and response to therapy. Hepatology 1998;28:296–301.
   PubMed Web of Science ®Google Scholar
• Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci USA 1997;94:2557–62.
   PubMed Web of Science ®Google Scholar
• Ludwig J, Dickson ER, MacDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978;379:103–12.
   PubMed Web of Science ®Google Scholar
• Bode C, Kugler V, Bode JC. Endotoxemia in patients with alcoholic and nonalcoholic cirrhosis and in subjects with no evidence of chronic liver disease following acute alcohol excess. J Hepatol 1987;4:8–14.
   PubMed Web of Science ®Google Scholar
• Criado-Jimenez M, Rivas-Cabanero L, Martin-Oterino JA, Lopez-Novoa JM, Sanchez-Rodriguez A. Nitric oxide production by mononuclear leukocytes in alcoholic cirrhosis. J Mol Med 1995;73:31–3.
   PubMedGoogle Scholar
• Rao RK, Seth A, Sheth P. Recent advances in alcoholic liver disease I. Role of intestinal permeability and endotoxemia in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004;286:G881–4.
   PubMed Web of Science ®Google Scholar
• Bode C, Vollmer E, Hug J, Bode JC. Increased permeability of the gut to polyethylene glycol and dextran in rats fed alcohol. Ann N Y Acad Sci 1991;625:837–40.
   PubMedGoogle Scholar
• Werling D, Jann OC, Offord V, Glass EJ, Coffey TJ. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol 2008;30:124–30.
   Google Scholar
• Testro AG, Visvanathan K. Toll-like receptors and their role in gastrointestinal disease. J Gastroenterol Hepatol 2009;24:943–54.
   PubMed Web of Science ®Google Scholar
• Nagata K, Suzuki H, Sakaguchi S. Common pathogenic mechanism in development progression of liver injury caused by non-alcoholic or alcoholic steatohepatitis. J Toxicol Sci 2007;32:453–68.
   PubMedGoogle Scholar
• Uesugi T, Froh M, Arteel GE, Bradford BU, Thurman RG. Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice. Hepatology 2001;34:101–8.
   PubMed Web of Science ®Google Scholar
• Rivera CA, Adegboyega P, van Rooijen N, Tagalicud A, Allman M, Wallace M. Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis. J Hepatol 2007;47:571–9.
   PubMed Web of Science ®Google Scholar
• Schwabe RF, Seki E, Brenner DA. Toll-like receptor signaling in the liver. Gastroenterology 2006;130:1886–900.
   PubMed Web of Science ®Google Scholar
• Mehal WZ, Azzaroli F, Crispe IN. Immunology of the healthy liver: old questions and new insights. Gastroenterology 2001;120:250–60.
   PubMed Web of Science ®Google Scholar
• Crispe IN. Hepatic T cells and liver tolerance. Nat Rev Immunol 2003;3:51–62.
   PubMed Web of Science ®Google Scholar